Tag: post-translational modifications in cancer

In a groundbreaking study that merges proteomics with advanced glycoproteomic analysis, researchers have unveiled significant insights into glioblastoma multiforme (GBM), ...

Emerging research published in Genes & Immunity unveils a groundbreaking prognostic signature based on post-translational acylation modifications, illuminating new frontiers ...

Recent advancements in cancer research have uncovered intriguing mechanisms that tumors employ to evade the immune system. One such breakthrough ...

In a groundbreaking study published in the Journal of Translational Medicine, researchers have unveiled a significant advancement in understanding prostate ...

Peptidyl-arginine deiminase 2 (PAD2) has emerged as a pivotal enzyme driving the progression of pancreatic ductal adenocarcinoma (PDAC), one of ...

Fucosylation stands as a pivotal post-translational modification intricately woven into the molecular fabric of cellular biology. This biochemical process facilitates ...

In a groundbreaking study poised to reshape therapeutic strategies against pediatric liver cancer, researchers have unveiled a pivotal mechanism by ...

In the relentless search to understand cancer's evasive tactics, renal cell carcinoma (RCC), a complex kidney malignancy, stands out for ...

In a groundbreaking new study published in Nature Communications, researchers have unveiled a previously underappreciated mechanism driving the aggressive adaptability ...

In the relentless quest to unravel the complex mechanisms underlying glioblastoma—the most aggressive and lethal form of brain cancer—new research ...